Physician profile
Erin E Spies
NPI 1194051854
$981.79
in general payments reported to CMS, 2019-2025
14 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $147 · 2021: $51.25 · 2022: $61.83 · 2023: $12.69 · 2024: $200 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $225.24 | 2019-2022 | |
| Pfizer INC. | $161.93 | 2019-2025 | |
| Cranial Technologies, INC | $148.26 | 2019-2025 | Doc Band |
| Corium, LLC | $112.93 | 2024 | Azstarys |
| Merck Sharp & Dohme LLC | $78.48 | 2019-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Glaxosmithkline, LLC. | $63.88 | 2019-2022 | |
| Tris Pharma INC | $45.68 | 2019 | |
| Collegium Pharmaceutical, INC. | $42.83 | 2025 | Jornay Pm |
| Genentech USA, INC. | $20.99 | 2019 | |
| Dermira, INC. | $18.73 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.94 | 2019 | |
| Biomarin Pharmaceutical INC. | $16.84 | 2024 | Voxzogo 1.2mg |
| Shire North American Group INC | $15.44 | 2019 | |
| Kaleo, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Spies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.